Atara Biotherapeutics Profit Margin 2013-2019 | ATRA

Current and historical gross margin, operating margin and net profit margin for Atara Biotherapeutics (ATRA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Atara Biotherapeutics net profit margin as of September 30, 2019 is 0%.
Atara Biotherapeutics Annual Profit Margins
Atara Biotherapeutics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.710B $0.000B
Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. The company's lead programs are focused on myostatin and activin, members of the TGF-beta family of proteins that have demonstrated the potential to have therapeutic benefit in a number of clinical indications. Its lead product candidate is PINTA 745, which is in a Phase II clinical trial for the treatment of protein-energy wasting in end-stage renal disease patients. Atara Biotherapeutics, Inc. is headquartered in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $130.524B 15.04
CSL (CSLLY) Australia $82.701B 0.00
Gilead Sciences (GILD) United States $80.122B 9.93
Celgene (CELG) United States $78.580B 11.22
Vertex Pharmaceuticals (VRTX) United States $53.256B 54.36
Biogen (BIIB) United States $50.865B 8.73
Illumina (ILMN) United States $43.838B 48.10
Regeneron Pharmaceuticals (REGN) United States $38.254B 16.75
Alexion Pharmaceuticals (ALXN) United States $23.707B 11.71
Seattle Genetics (SGEN) United States $19.231B 0.00
Incyte (INCY) United States $18.832B 43.72
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.631B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.677B 0.00
Genmab (GNMSF) Denmark $13.325B 58.86
Galapagos (GLPG) Belgium $10.490B 27.03
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Exact Sciences (EXAS) United States $10.159B 0.00
Alnylam Pharmaceuticals (ALNY) United States $10.099B 0.00
BeiGene (BGNE) Cayman Islands $9.368B 0.00
QIAGEN (QGEN) Netherlands $7.994B 26.07
Bio-Techne Corp (TECH) United States $7.809B 52.27
Amarin (AMRN) Ireland $7.677B 0.00
Sarepta Therapeutics (SRPT) United States $7.529B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.148B 0.00
Guardant Health (GH) United States $7.056B 0.00
Moderna (MRNA) United States $6.082B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.675B 14.43
Reata Pharmaceuticals (RETA) United States $5.644B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.205B 0.00
Exelixis (EXEL) United States $4.974B 13.99
Ascendis Pharma (ASND) Denmark $4.764B 0.00
China Biologic Products (CBPO) China $4.555B 25.66
Repligen (RGEN) United States $4.332B 78.51
Spark Therapeutics (ONCE) United States $4.290B 0.00
Bluebird Bio (BLUE) United States $4.249B 0.00
Medicines (MDCO) United States $4.210B 0.00
Mirati Therapeutics (MRTX) United States $3.972B 0.00
Blueprint Medicines (BPMC) United States $3.607B 0.00
Adaptive Biotechnologies (ADPT) United States $3.389B 0.00
Immunomedics (IMMU) United States $3.353B 0.00
MorphoSys AG (MOR) Germany $3.326B 0.00
Alkermes (ALKS) Ireland $3.054B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.036B 0.00
Genmab (GMAB) Denmark $2.868B 5.91
Emergent Biosolutions (EBS) United States $2.824B 28.06
Intercept Pharmaceuticals (ICPT) United States $2.747B 0.00
Halozyme Therapeutics (HALO) United States $2.589B 0.00
MyoKardia (MYOK) United States $2.475B 0.00
NeoGenomics (NEO) United States $2.435B 130.28
Amicus Therapeutics (FOLD) United States $2.433B 0.00
Acceleron Pharma (XLRN) United States $2.370B 0.00
UniQure (QURE) Netherlands $2.347B 0.00
Arena Pharmaceuticals (ARNA) United States $2.319B 5.39
Zai Lab (ZLAB) China $2.247B 0.00
RA PHARMCTL INC (RARX) United States $2.202B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.154B 0.00
Cambrex (CBM) United States $2.019B 25.47
Ligand Pharmaceuticals (LGND) United States $1.932B 37.16
Akcea Therapeutics (AKCA) United States $1.809B 0.00
Myriad Genetics (MYGN) United States $1.794B 26.50
Insmed (INSM) United States $1.738B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.628B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.563B 0.00
Denali Therapeutics (DNLI) United States $1.455B 0.00
Epizyme (EPZM) United States $1.390B 0.00
Zymeworks (ZYME) Canada $1.386B 0.00
REGENXBIO (RGNX) United States $1.347B 0.00
Coherus BioSciences (CHRS) United States $1.346B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.319B 0.00
Innoviva (INVA) United States $1.232B 3.63
Editas Medicine (EDIT) United States $1.179B 0.00
Zealand Pharma (ZLDPF) Denmark $1.143B 0.00
Sangamo Therapeutics (SGMO) United States $1.123B 0.00
Fate Therapeutics (FATE) United States $1.113B 0.00
Alector (ALEC) United States $1.078B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.053B 0.00
Zealand Pharma (ZEAL) Denmark $1.005B 11.28
WAVE Life Sciences (WVE) Singapore $0.961B 0.00
Arvinas (ARVN) United States $0.958B 0.00
Athenex (ATNX) United States $0.915B 0.00
Codexis (CDXS) United States $0.891B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.886B 0.00
Anika Therapeutics (ANIK) United States $0.864B 28.02
Cara Therapeutics (CARA) United States $0.858B 0.00
Vericel (VCEL) United States $0.841B 313.50
ZIOPHARM Oncology Inc (ZIOP) United States $0.824B 0.00
Pharming Group (PHGUF) Netherlands $0.799B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.799B 6.72
BAVARIAN NORDIC (BVNRY) Denmark $0.791B 0.00
Principia Biopharma (PRNB) United States $0.743B 0.00
Heska (HSKA) United States $0.717B 183.26
Twist Bioscience (TWST) United States $0.713B 0.00
ANI Pharmaceuticals (ANIP) United States $0.686B 11.69
DBV Technologies S.A (DBVT) France $0.684B 0.00
Intellia Therapeutics (NTLA) United States $0.681B 0.00
Revance Therapeutics (RVNC) United States $0.680B 0.00
MiMedx (MDXG) United States $0.648B 0.00
Mesoblast (MESO) Australia $0.609B 0.00
GENFIT S.A (GNFT) France $0.584B 0.00
Adverum Biotechnologies (ADVM) United States $0.583B 0.00
Cellectis S.A (CLLS) France $0.564B 0.00
Retrophin (RTRX) United States $0.558B 0.00
UROGEN PHARMA (URGN) United States $0.546B 0.00
BioDelivery Sciences (BDSI) United States $0.537B 0.00
Agenus (AGEN) United States $0.518B 0.00
Intra-Cellular Therapies (ITCI) United States $0.495B 0.00
Precision BioSciences (DTIL) United States $0.481B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
Cytokineticsorporated (CYTK) United States $0.479B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.473B 0.00
Kadmon Holdings (KDMN) United States $0.462B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.447B 0.00
PHARMA MAR SA (PHMMF) Spain $0.445B 0.00
AC Immune SA (ACIU) Switzerland $0.441B 10.20
Stemline Therapeutics (STML) United States $0.417B 0.00
Prothena (PRTA) Ireland $0.410B 0.00
Dynavax Technologies (DVAX) United States $0.383B 0.00
Merus (MRUS) Netherlands $0.372B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.369B 2.55
Arcus Biosciences (RCUS) United States $0.366B 0.00
Clovis Oncology (CLVS) United States $0.359B 0.00
Cellular Biomedicine (CBMG) United States $0.348B 0.00
Puma Biotechnology (PBYI) United States $0.342B 0.00
PDL BioPharma (PDLI) United States $0.331B 8.29
AMAG Pharmaceuticals (AMAG) United States $0.329B 0.00
Bellus Health (BLU) Canada $0.319B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
Kindred Biosciences (KIN) United States $0.318B 0.00
Pfenex (PFNX) United States $0.305B 0.00
Avid Bioservices (CDMO) United States $0.302B 0.00
AnaptysBio (ANAB) United States $0.298B 0.00
Theratechnologies (THTX) Canada $0.284B 0.00
Compugen (CGEN) Israel $0.283B 0.00
Protagonist Therapeutics (PTGX) United States $0.282B 0.00
Geron (GERN) United States $0.280B 0.00
Seres Therapeutics (MCRB) United States $0.258B 0.00
ADMA Biologics Inc (ADMA) United States $0.257B 0.00
Gritstone Oncology (GRTS) United States $0.256B 0.00
Biofrontera AG (BFRA) Germany $0.253B 378.53
Sutro Biopharma (STRO) United States $0.249B 0.00
Cel-Sci (CVM) United States $0.248B 0.00
Scholar Rock Holding (SRRK) United States $0.245B 0.00
MannKind (MNKD) United States $0.242B 0.00
CytomX Therapeutics (CTMX) United States $0.241B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.235B 0.00
Albireo Pharma (ALBO) United States $0.234B 0.00
Kamada (KMDA) Israel $0.230B 6.72
Aeglea BioTherapeutics (AGLE) United States $0.229B 0.00
Inovio Pharmaceuticals (INO) United States $0.229B 0.00
Syros Pharmaceuticals (SYRS) United States $0.222B 0.00
XOMA (XOMA) United States $0.216B 0.00
Athersys (ATHX) United States $0.213B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
Sorrento Therapeutics (SRNE) United States $0.210B 0.00
OSMOTICA PHARM (OSMT) United States $0.205B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.203B 0.00
Cue Biopharma (CUE) United States $0.202B 0.00
Spero Therapeutics (SPRO) United States $0.200B 0.00
Exicure (XCUR) United States $0.187B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.187B 0.00
Palatin Technologies (PTN) United States $0.181B 4.97
ChromaDex (CDXC) United States $0.180B 0.00
Senesco Technologies (ELOX) United States $0.168B 0.00
Arsanis (XFOR) United States $0.164B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.159B 0.00
Dyadic (DYAI) United States $0.156B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.152B 0.00
Alcobra (ARCT) United States $0.152B 0.00
Nicox SA (NICXF) France $0.150B 0.00
Cerecor (CERC) United States $0.147B 0.00
Prometic Life Sciences (PFSCF) Canada $0.146B 0.00
Affimed (AFMD) Germany $0.146B 0.00
Five Prime Therapeutics (FPRX) United States $0.136B 0.00
Enzo Biochem (ENZ) United States $0.135B 0.00
CorMedix Inc (CRMD) United States $0.134B 0.00
Mersana Therapeutics (MRSN) United States $0.133B 0.00
Northwest Biotherapeutics (NWBO) United States $0.132B 0.00
Ophthotech (ISEE) United States $0.131B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Emmaus Life Sciences (EMMA) United States $0.128B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.125B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.123B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.117B 0.00
BioTime (LCTX) United States $0.116B 5.98
Abeona Therapeutics (ABEO) United States $0.115B 0.00
SESEN BIO, INC (SESN) United States $0.114B 0.00
Aptinyx (APTX) United States $0.114B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.114B 0.00
Menlo Therapeutics (MNLO) United States $0.112B 0.00
PHASEBIO PHARMA (PHAS) United States $0.112B 0.00
Fortress Biotech (FBIO) United States $0.112B 0.00
Novavax (NVAX) United States $0.111B 0.00
NantKwest (NK) United States $0.109B 0.00
OvaScience (MLND) United States $0.102B 0.00
VBI Vaccines (VBIV) United States $0.100B 0.00
Acorda Therapeutics (ACOR) United States $0.093B 0.00
Celyad SA (CYAD) Belgium $0.090B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.089B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
Aduro Biotech (ADRO) United States $0.088B 0.00
VTv Therapeutics (VTVT) United States $0.087B 0.00
Arbutus Biopharma (ABUS) Canada $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Strongbridge Biopharma (SBBP) United States $0.085B 2.28
Aquinox Pharmaceuticals (NLTX) Canada $0.082B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
Synlogic (SYBX) United States $0.075B 0.00
Verastem (VSTM) United States $0.074B 0.00
ARAVIVE, INC (ARAV) United States $0.074B 0.00
Prima BioMed (IMMP) Australia $0.071B 0.00
Liquidia Technologies (LQDA) United States $0.069B 0.00
Trevena (TRVN) United States $0.069B 0.00
Vaccinex (VCNX) United States $0.068B 0.00
Selecta Biosciences (SELB) United States $0.067B 0.00
Checkpoint Therapeutics (CKPT) United States $0.066B 0.00
Catalyst Biosciences (CBIO) United States $0.063B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.063B 0.00
Idera Pharmaceuticals (IDRA) United States $0.060B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.057B 0.00
Proteostasis Therapeutics (PTI) United States $0.057B 0.00
Orgenesis (ORGS) United States $0.054B 3.51
Applied Genetic Technologies (AGTC) United States $0.053B 0.00
China Health Industries Holdings (CHHE) China $0.052B 15.78
Pluristem Therapeutics (PSTI) Israel $0.051B 0.00
Curis (CRIS) United States $0.050B 0.00
Organovo Holdings (ONVO) United States $0.048B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
VistaGen Therapeutics (VTGN) United States $0.047B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.046B 0.00
AquaBounty Technologies (AQB) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.045B 0.00
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
AIT Therapeutics (XAIR) United States $0.043B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Evogene (EVGN) Israel $0.039B 0.00
Stellar Biotechnologies (EDSA) Canada $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Unum Therapeutics (UMRX) United States $0.033B 0.00
Oncobiologics (OTLK) United States $0.032B 0.00
Protalix BioTherapeutics (PLX) Israel $0.030B 0.00
VIVUS (VVUS) United States $0.030B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.93
Caladrius Biosciences (CLBS) United States $0.028B 0.00
Entera Bio (ENTX) Israel $0.028B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
BioCardia (BCDA) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
Celsion (CLSN) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Soligenix (SNGX) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.020B 0.00
Apricus Biosciences (SEEL) United States $0.019B 0.00
Alimera Sciences (ALIM) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.018B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.012B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.004B 0.00
Neuralstem (SNCA) United States $0.002B 0.00